You are here

Advantages and Disadvantages of Biomarker-based Endotyping for Critical Care

Loading the player...
Description
Related Content

Author

Nadir Yehya MD

Kate Madden

Learn More

Description

In this video, Dr. Nadir Yehya, Assistant Professor of Anesthesiology and Critical Care Medicine at the Children's Hospital of Philadelphia and the University of Pennsylvania, discusses the advantages and disadvantages of biomarkers in critical care research. He covers the specifics of how biomarkers influence endotyping, subphenotyping, and enrichment for critical care trials (with a focus on sepsis and ARDS). He also provides an overview of existing literature in adult and pediatric sepsis and ARDS, as well as the strengths and weaknesses of using biomarkers in research.

 

Initial publication: February 24, 2020.

 

Podcast:

Listen to the audio track of this video.

Subscribe to a podcast of audio recordings from this and other OPENPediatrics videos using the blue “Subscribe” button above.

 

Citation: Yehya, N, Zackin, B, Daniel, D, Madden, K. Advantages and Disadvantages of Biomarker-based Endotyping for Critical Care. 2/2020. Online Video. OPENPediatrics. https://www.openpediatrics.org/assets/video/advantages-and-disadvantages-biomarker-based-endotyping-critical-care.

Topics: World Shared Practice Forum Critical Care Anesthesiology Rheumatology